Catherine M Viscoli
Affiliation: Yale University
- Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke TrialCatherine M Viscoli
Yale University School of Medicine, New Haven, CT Electronic address
Am Heart J 168:823-9.e6. 2014....
- Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST)Catherine M Viscoli
Yale University School of Medicine, Department of Internal Medicine, 333 Cedar St, Room IE 61 SHM, PO Box 208025, New Haven, CT 06520 8025, USA
Am J Obstet Gynecol 192:387-93. 2005..This study was undertaken to assess whether estrogen therapy (ET) reduces the risk of cognitive decline in women with cerebrovascular disease...
- Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic strokeWalter N Kernan
Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520 8025, USA
Arch Intern Med 165:227-33. 2005..We conducted this study to determine if IGT and DGT are sufficiently common among patients with TIA and ischemic stroke to warrant therapeutic trials of antihyperglycemic agents...
- Decline in physical performance among women with a recent transient ischemic attack or ischemic stroke: opportunities for functional preservation a report of the Women's Estrogen Stroke TrialWalter N Kernan
Department of Medicine, Yale University School of Medicine, P O Box 208025, New Haven, CT 06520 8025, USA
Stroke 36:630-4. 2005..To examine this possibility, we measured change in physical performance, independent of subsequent stroke, among women with a recent ischemic stroke or transient ischemic attack (TIA)...
- Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic strokeWalter N Kernan
Department of Medicine, Yale University School of Medicine, PO Box 208025, New Haven, CT 06520 8025, USA
Stroke 34:1431-6. 2003....
- What do medical schools teach about women's health and gender differences?Janet B Henrich
Medicine and of Obstetrics and Gynecology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
Acad Med 81:476-82. 2006..To examine the curricula of U.S. medical schools to assess the inclusion of women's health and gender-specific information and identify institutional characteristics associated with this content...
- Altruism as a reason for participation in clinical trials was independently associated with adherenceJulie R Rosenbaum
Yale Primary Care Internal Medicine Residency, Waterbury Hospital Health Center, Department of Medicine, CT 06721, USA
J Clin Epidemiol 58:1109-14. 2005..To determine whether altruism as reason for participation in research is independently associated with adherence to a medical regimen in a clinical trial...
- Medical students' assessment of education and training in women's health and in sex and gender differencesJanet B Henrich
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
J Womens Health (Larchmt) 17:815-27. 2008..The authors surveyed U.S. medical students to learn their perceptions of the adequacy of women's health and sex/gender-specific teaching and of their preparedness to care for female patients...
- Litigation seeking access to data from ongoing clinical trials: a threat to clinical researchWalter N Kernan
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
JAMA Intern Med 174:1502-4. 2014..We describe herein general issues raised by subpoenas for trial data and the particular case of a 2012 subpoena served on investigators from Yale University who were successful in winning reprieve from Connecticut Superior Court. ..
- Adherence reporting in randomized controlled trialsZe Zhang
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
Clin Trials 11:195-204. 2014..Adherence may also be an indicator of research quality and treatment acceptance by participants. Despite the importance of adherence in RCT research, little is known about current practices for its measurement and reporting...
- Disagreement between students and preceptors regarding the value of teaching behaviors for ambulatory care settingsWalter N Kernan
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06519, USA
Teach Learn Med 20:143-50. 2008..Medical students and preceptors commonly disagree on methods of clinical instruction in ambulatory care, although the extent of the problem is not documented...
- Influence of race, clinical, and other socio-demographic features on trial participationGiselle Corbie-Smith
Department of Social Medicine, Division of General Medicine and Clinical Epidemiology, University of North Carolina at Chapel Hill, Wing D, Medical School, CB 7240, Chapel Hill, NC 27599, USA
J Clin Epidemiol 56:304-9. 2003..94-0.97), hysterectomy (OR 1.78, 95% CI 1.27-2.50), no cognitive impairment (OR 1.70, 95% CI 1.10-2.63), history of volunteerism (OR 1.62, 95% CI 1.02-2.63), and previous estrogen use (RR 1.58, 95% CI 1.08-2.30)...
- Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiableJoseph P Broderick
Department of Neurology, University of Cincinnati, College of Medicine, Cincinnati, Ohio 45267, USA
Stroke 34:1375-81. 2003..To identify risk factors for subarachnoid hemorrhage (SAH) and intracerebral hemorrhage, we designed a case-control study of men and women 18 to 49 years of age (the Hemorrhagic Stroke Project [HSP]). This report focuses on SAH...
- Clinical assessment of function among women with a recent cerebrovascular event: a self-reported versus performance-based measurePamela L Owens
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
Ann Intern Med 136:802-11. 2002..Self-reported functional status is a commonly used health measure in clinical settings, yet the optimal approach for assessing function is often debated...
- Major risk factors for intracerebral hemorrhage in the young are modifiableEdward Feldmann
Department of Clinical Neurosciences, Brown Medical School, 110 Lockwood St, Providence, RI 02903, USA
Stroke 36:1881-5. 2005..To identify risk factors for intracerebral hemorrhage (ICH), we examined data from the Hemorrhagic Stroke Project (HSP), a case-control study of hemorrhagic stroke among men and women aged 18 to 49 years...
- Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysisZachary T Bloomgarden
Mount Sinai School of Medicine, 35 East 85th Street, New York, NY 10028, USA
Diabetes Care 29:2137-9. 2006